Back
Ligand Pharmaceuticals, Inc. Vs. Elevance Health, Inc. Industry Stock Comparison
Buy
57
LGND
Ligand Pharmaceuticals, Inc.
Last Price:
$197.40
Seasonality Move:
6.01%
Sell
40
ELV
Elevance Health, Inc.
Last Price:
$343.53
Seasonality Move:
9.74%
Buy
57
Ligand Pharmaceuticals, Inc. (LGND)
is a Buy
Is Ligand Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Ligand Pharmaceuticals, Inc. [LGND] share price is $197.14. The Score for LGND is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Elevance Health, Inc. (ELV)
is a Sell
Is Elevance Health, Inc. a Buy, Sell or Hold?
-
The current Elevance Health, Inc. [ELV] share price is $343.30. The Score for ELV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
ELV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LGND Stock Price Chart
What is Ligand Pharmaceuticals, Inc.'s stock price today?
-
The Ligand Pharmaceuticals, Inc. share price today is $197.14Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing buying pressure, which is a positive indicator for future bullish movement.
ELV Stock Price Chart
What is Elevance Health, Inc.'s stock price today?
-
The Elevance Health, Inc. share price today is $343.30The current trend is moderately bullish and ELV is experiencing selling pressure, which indicates risk of future bearish movement.
LGND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.71 | Buy |
| Relative Strength Index (14 RSI): | 54.27 | Buy |
| Chaikin Money Flow: | 52012 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (188.14 - 202.36) | Buy |
| Bollinger Bands (100): | (161.93 - 197.37) | Buy |
ELV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.07 | Buy |
| Relative Strength Index (14 RSI): | 53.48 | Buy |
| Chaikin Money Flow: | -297046 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (325.81 - 349.85) | Buy |
| Bollinger Bands (100): | (306.6 - 345.12) | Buy |
LGND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 196.43 | Buy |
| 20-day SMA: | 193.32 | Buy |
| 50-day SMA: | 194.32 | Buy |
| 200-day SMA: | 145.91 | Buy |
| 8-day EMA: | 195.99 | Buy |
| 20-day EMA: | 194.78 | Buy |
| 50-day EMA: | 190.81 | Buy |
| 200-day EMA: | 157.21 | Buy |
ELV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 346.83 | Sell |
| 20-day SMA: | 341.39 | Buy |
| 50-day SMA: | 334.47 | Buy |
| 200-day SMA: | 355.31 | Sell |
| 8-day EMA: | 344.54 | Sell |
| 20-day EMA: | 341.34 | Buy |
| 50-day EMA: | 335.85 | Buy |
| 200-day EMA: | 354.26 | Sell |
Ligand Pharmaceuticals, Inc. Earnings Growth & LGND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.92 per share, and an increase next year of $0.84 per share.
Elevance Health, Inc. Earnings Growth & ELV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.97 per share, and a decrease next year of $3.04 per share.
Ligand Pharmaceuticals, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Elevance Health, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||